Dr. Eng Discusses the ADORE Trial in Rectal Cancer

Dr. Eng Discusses Results of the PRODIGE 7 TrialПодробнее

Locally Advanced Rectal Cancer: PROSPECT TrialПодробнее

Dr. Eng on Emerging Agents for Treatment of Anal CancerПодробнее

Dr. Paty on Patients With Rectal Cancer Ineligible for "Watch and Wait"Подробнее

Dr. Patel on Sequencing Therapy in Rectal CancerПодробнее

Recent Clinical Trial Data in Locally Advanced CRCПодробнее

Dr. VanderWalde on Personalizing Therapy in Rectal CancerПодробнее

Goals of Therapy in Refractory Colorectal CancerПодробнее

Postoperative Chemotherapy for Advanced Rectal CancerПодробнее

Cathy Eng, MD - Anal cancer's first randomized trial for inoperable disease the treatment standardПодробнее

Debate 4: Appropriate Pre-op Therapy in Rectal Cancer - Short-course RTПодробнее

John L Marshall, ASCO 2018 – PARP inhibitors for the personalized treatment of colorectal cancerПодробнее

Why is rectal cancer increasing among younger people?Подробнее

The rationale behind the ancillary study of the STAMPEDE AAP trialПодробнее

Darolutamide’s Role in Treating Nonmetastatic CRPCПодробнее

Rationale for neoadjuvant treatment rectal cancerПодробнее

My First Clinical Trial Experience From My CANCER DiagnosisПодробнее

The Phase 2 ASC2ESCALATE Trial Evaluating Asciminib for CML Patients | David Andorsky, MD | #ASH2024Подробнее

ARCHES trialПодробнее